The cash virtual companies have for drug development may be limited. In any event, a small biotech company, virtual or not, has nowhere near two billion dollars to bring a drug to market.

The pharmaceutical industry has rapidly adopted AI and GenAI to expedite drug discovery, development, and manufacturing processes. Companies like Dr Reddy's, Novartis, Sanofi, Johnson & Johnson ...

As it now costs a whopping $800 million to develop a new drug, American researchers have developed a forecasting computer model which could reduce drug development costs, saving hundreds of ...

The cost of drug development has skyrocketed, but disruptive technologies can bring it back down to earth. Over the past several decades, drug-development costs have risen significantly, from $250 ...

According to a recent study, the out-of-pocket clinical costs and capitalized clinical costs per approved drug were both lower for orphan drugs compared with nonorphan drugs.

The cost of making a new drug has grown to nearly $2.6B, according to the latest and greatest from Tufts Center for the Study of Drug Development (here). That’s a big and almost unfathomable ...

The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with "human-relevant methods ...

Conduit and Sarborg complete all milestones of Phase I of their AI-driven drug development collaboration, and commence transitioning to Phase II, which will focus on developing personalized ...

In the increasingly complex healthcare realm, a regular flow of drug introductions offers potential benefits to millions of patients. However, the biotech and pharmaceutical companies that develop ...

GenScript Launches GMP-like mRNA Solution to address phase-appropriate drug development needs Sponsored By GenScript May 26, 2025 8:00am Biotech ...